Home > Name List By 2 > 2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate

CAS No 15301-69-6 , 2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate

  • Name: 2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate
  • Synonyms: Flavoxatum;Urispas;2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate; Flavoxate HCI; Flavoxato; Flavoxate HCL; Flavossato [DCIT]; Flavossato; Flavoxate [INN:BAN];
  • CAS Registry Number:
  • Flash Point: 294.9°C
  • Boiling Point: 564.1°Cat760mmHg
  • Density: 1.203g/cm3
  • Refractive index: 1.591
  • Flash Point: 294.9°C
  • EINECS: 239-337-5
  • Molecular Weight: 391.4596
  • InchiKey: SPIUTQOUKAMGCX-UHFFFAOYSA-N
  • InChI: InChI=1S/C24H25NO4/c1-17-21(26)19-11-8-12-20(23(19)29-22(17)18-9-4-2-5-
    10-18)24(27)28-16-15-25-13-6-3-7-14-25/h2,4-5,8-12H,3,6-7,13-16H2,1H3
  • Molecular Formula: C24H25NO4
  • Molecular Structure:CAS No:15301-69-6 2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate

Related products

Search by region :

Select to

15301-69-6 Flavoxate

  • IUPAC NAME-2-(1-piperidyl)ethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate MOLECULAR FORMULA-C24H25NO4 MOLAR MASS-391.46 g/mol Flavoxate is an anticholinergic with antimuscarinic effects. Its muscle relaxant properties may be due to a direct actio...
  • India Swapnroop Drugs & Pharmaceuticals [Manufacturer, Trading Company]
  • Tel: 91-240-6641875
  • Fax: 91-240-6641875
  • Address: Harsool Aurangabad,MaharashtraIndia
Contact Supplier

15301-69-6 FLAVOXATE

  • Canada TLC PharmaChem., Inc. [Manufacturer]
  • Tel: 905-760-1098
  • Fax: 905-760-2098
  • Address: TLC PharmaChem., Inc.
    5-150 Connie Crescent
    Concord, Ontario
    L4K 1L9, Canada null,nullCanada
Contact Supplier

15301-69-6 FLAVOXATE

  • United States LGM Pharma [Manufacturer]
  • Tel: 561-981-9994
  • Fax: 561-892-0580
  • Address: 922 Clint Moore Road
    Boca Raton, FL 33487 null,nullUnited States
Contact Supplier

15301-69-6 FLAVOXATE HCL

  • Canada Synth?se AptoChem Inc. [Manufacturer]
  • Tel: 514-496-4252
  • Fax: 514-496-4253
  • Address: Synth?se AptoChem Inc.
    6100 Royalmount Ave
    Montreal, QC
    Canada
    H4P 2R2 null,nullCanada
Contact Supplier

15301-69-6 FLAVOXATE

  • CBNumber: CB2341499 Chemical Name: FLAVOXATE Molecular Formula: C24H25NO4 Formula Weight: 391.46 CAS No.: 15301-69-6 Usage Use urinary tract drug use.
  • China jinan jiaquan chemical [Manufacturer]
  • Tel: 86-531-62318366
  • Fax: 86-531-62318377
  • Address: Yidonghuayuan Huaxin Road Licheng District Jinan China jinan,nullChina
Contact Supplier

15301-69-6 FLAVOXATE HCL

  • China Nanjing Chemlin Chemical Industry Co.,Ltd. [Manufacturer]
  • Tel: +86 25 8369-7070/ +86 138 51816776 (Mobile)
  • Fax: +86 25 8345-3275
  • Address: Rm.902 Longyin Plaza,
    No. 217 Zhongshan Rd.
    (N)Nanjing 210009,China null,nullChina
Contact Supplier

Select to

1/1
References of 2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate
Title: Flavoxate
CAS Registry Number: 15301-69-6
CAS Name: 3-Methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid 2-(1-piperidinyl)ethyl ester
Synonyms: 3-methylflavone-8-carboxylic acid b-piperidinoethyl ester; 2-piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate; 2-piperidinoethyl 3-methylflavone-8-carboxylate
Molecular Formula: C24H25NO4
Molecular Weight: 391.46
Percent Composition: C 73.64%, H 6.44%, N 3.58%, O 16.35%
Literature References: Smooth muscle relaxant. Prepn of the hydrochloride: P. Da Re et al., J. Med. Pharm. Chem. 2, 263 (1960); P. Da Re, US 2921070 and US 3350411 (1960 to Recordati and 1967 to Seceph). Pharmacological studies: I. Setnikar et al., J. Pharmacol. Exp. Ther. 130, 356 (1960). Mechanism of action: P. Cazzulani et al., Arch. Int. Pharmacodyn. 274, 189 (1985). Pharmacokinetics in rats: I. Setnikar et al., Arzneim.-Forsch. 25, 1916 (1975); in man: M. Bertoli et al., Pharmacol. Res. Commun. 8, 417 (1976). In vivo activity: C. Pietra, P. Cazzulani, Farmaco Ed. Prat. 41, 267 (1986). Determn in tissues: A. Cova, I. Setnikar, Arzneim.-Forsch. 25, 1707 (1975). Clinical evaluations: D. V. Bradley, R. J. Cazort, J. Clin. Pharmacol. 10, 65 (1970); A. Zanollo, F. Catanzaro, Urol. Int. 35, 176 (1980). Clinical comparison with phenazopyridine: S. Gould, Urology 5, 612 (1975). Short review: R. Ruffmann, A. Sartini, Drugs Exp. Clin. Res. 13, 57 (1987).
Properties: Crystals, pK 7.3. Soly in water at 37°: 0.001% (w/v). Sol in ethanol and chloroform. LD50 in rats (mg/kg): 1110 orally; 20.8 i.v. (Setnikar, 1975).
pKa: pK 7.3
Toxicity data: LD50 in rats (mg/kg): 1110 orally; 20.8 i.v. (Setnikar, 1975)
 
Derivative Type: Hydrochloride
CAS Registry Number: 3717-88-2
Manufacturers' Codes: DW-61; Rec-7-0040
Trademarks: Bladderon (Nippon Shinyaku); Genurin (Recordati); Patricin (Kaken); Spasuret (Asche); Urispas (SKB)
Molecular Formula: C24H25NO4.HCl
Molecular Weight: 427.92
Percent Composition: C 67.36%, H 6.12%, N 3.27%, O 14.96%, Cl 8.28%
Properties: Crystals from ethanol + ether, mp 232-234°. LD50 i.v. in rats: 27.4 mg/kg (Cazzulani).
Melting point: mp 232-234°
Toxicity data: LD50 i.v. in rats: 27.4 mg/kg (Cazzulani)
 
Derivative Type: Succinate
CAS Registry Number: 28782-19-6
Molecular Formula: C24H25NO4.C4H6O4
Molecular Weight: 509.55
Percent Composition: C 66.00%, H 6.13%, N 2.75%, O 25.12%
Properties: Soly in water at 37°: 33.7% (w/v).
 
Therap-Cat: Antispasmodic; in treatment of urinary incontinence.
Keywords: Antispasmodic; Antimuscarinic.